English

Flexion Therapeutics Inc

EDGAR

FLXN Quarterly report (10-Q) · filed 2021-11-12

89 filing records in this dataset, filed from 2014-01-08 to 2021-11-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

21.3 million USD

2021 Q3 · USD

Exact inputs and evidence

Revenue: 21326000 USD Source

Operating margin

-113.28%

2021 Q3 · %

Exact inputs and evidence

Operating Income: -24158000 USD Source
Revenue: 21326000 USD Source

Operating cash flow

-14.2 million USD

2021 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -51441000 USD Source
Operating Cash Flow: -37236000 USD Source

Free cash flow

-14.7 million USD

2021 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -51441000 USD Source
Operating Cash Flow: -37236000 USD Source
Capital Expenditure: 1737000 USD Source
Capital Expenditure: 1265000 USD Source

Cash and cash equivalents: 137 million USD 2021-09-30 Source
Exact value

136824000 USD
Long-term debt including current maturities: 55.1 million USD 2021-09-30 Source
Exact value

55100000 USD
Shares outstanding: 49.4 million shares 2021-09-30 Source
Exact value

49403034 shares

Reported share-count change

0.20% · 97.5 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

49305545 shares · 2020-09-30· Source
49403034 shares · 2021-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

100 million USD

2020-10-01 – 2021-09-30

Exact inputs and evidence

Revenue: 26310000 USD · 2020-10-01 – 2020-12-31 Source
Revenue: 24589000 USD · 2021-01-01 – 2021-03-31 Source
Revenue: 28175000 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 21326000 USD · 2021-07-01 – 2021-09-30 Source

Net income

-101 million USD

2020-10-01 – 2021-09-30

Exact inputs and evidence

Net income: -19647000 USD · 2020-10-01 – 2020-12-31 Source
Net income: -28556000 USD · 2021-01-01 – 2021-03-31 Source
Net income: -22208000 USD · 2021-04-01 – 2021-06-30 Source
Net income: -30312000 USD · 2021-07-01 – 2021-09-30 Source

Operating cash flow

-61.2 million USD

2020-10-01 – 2021-09-30

Exact inputs and evidence

Operating cash flow: -70561000 USD · 2020-01-01 – 2020-12-31 Source
Operating cash flow: -60819000 USD · 2020-01-01 – 2020-09-30 Source
Operating cash flow: -18474000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -37236000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -18474000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -51441000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -37236000 USD · 2021-01-01 – 2021-06-30 Source

Capital expenditure

2.95 million USD

2020-10-01 – 2021-09-30

Exact inputs and evidence

Capital expenditure: 10069000 USD · 2020-01-01 – 2020-12-31 Source
Capital expenditure: 8860000 USD · 2020-01-01 – 2020-09-30 Source
Capital expenditure: 801000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 1265000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 801000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 1737000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 1265000 USD · 2021-01-01 – 2021-06-30 Source

Free cash flow

-64.1 million USD

2020-10-01 – 2021-09-30

Exact inputs and evidence

Operating cash flow: -70561000 USD · 2020-01-01 – 2020-12-31 Source
Operating cash flow: -60819000 USD · 2020-01-01 – 2020-09-30 Source
Operating cash flow: -18474000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -37236000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -18474000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -51441000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -37236000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 10069000 USD · 2020-01-01 – 2020-12-31 Source
Capital expenditure: 8860000 USD · 2020-01-01 – 2020-09-30 Source
Capital expenditure: 801000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 1265000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 801000 USD · 2021-01-01 – 2021-03-31 Source
Capital expenditure: 1737000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 1265000 USD · 2021-01-01 – 2021-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-11-12.

Financial data available through: 2020-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2020-12-31
Operating income: 9 of 11 periods available· newest 2020-12-31
Net income: 10 of 11 periods available· newest 2020-12-31
Operating cash flow: 9 of 11 periods available· newest 2020-12-31
Capital expenditure: 9 of 11 periods available· newest 2020-12-31
Total assets: 4 of 11 periods available· newest 2020-12-31
Total liabilities: 4 of 11 periods available· newest 2020-12-31
Current assets: 4 of 11 periods available· newest 2020-12-31
Current liabilities: 4 of 11 periods available· newest 2020-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2020-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2020-12-31
Shares outstanding: 4 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.3%

Prior period

USD 72.96 million

2019-01-01 – 2019-12-31
Current period

USD 85.55 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

85552000 − 72957000 = 12595000 USD

72957000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
85552000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Year-over-year change in Revenue: 12595000 USD Concept: fundies:Revenue Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 85552000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#1576195 Filing: 000156459021012050 Input fundies:Revenue: 72957000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#1577996 Filing: 000156459021012050
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 36.07 million

Prior period

−USD 149.77 million

2019-01-01 – 2019-12-31
Current period

−USD 113.71 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

-113706000 − -149773000 = 36067000 USD

-149773000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
-113706000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Year-over-year change in Net income: 36067000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -113706000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#3129446 Filing: 000156459021012050 Input fundies:NetIncome: -149773000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#3131354 Filing: 000156459021012050
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 78.2 million

Prior period

−USD 148.76 million

2019-01-01 – 2019-12-31
Current period

−USD 70.56 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

-70561000 − -148758000 = 78197000 USD

-148758000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
-70561000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Year-over-year change in Operating cash flow: 78197000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -70561000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2062346 Filing: 000156459021012050 Input fundies:OperatingCashFlow: -148758000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2064329 Filing: 000156459021012050
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+158.6%

Prior period

USD 3.89 million

2019-01-01 – 2019-12-31
Current period

USD 10.07 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

10069000 − 3894000 = 6175000 USD

3894000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
10069000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Year-over-year change in Capital expenditure: 6175000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 10069000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2073883 Filing: 000156459021012050 Input fundies:CapitalExpenditure: 3894000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2075677 Filing: 000156459021012050
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

Revenue USD 85.55 million 100% of revenue
Cost of revenue USD 19.25 million 22% of revenue
Operating expenses USD 159.32 million 186% of revenue
Operating income −USD 93.02 million −109% of revenue
Tax, interest and other Derived USD 20.69 million 24% of revenue
Net income −USD 113.71 million −133% of revenue

Cash

Operating cash flow −USD 70.56 million −82% of revenue
Capital expenditure USD 10.07 million 12% of revenue
Free cash flow Derived −USD 80.63 million −94% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 36,630% of revenue.
2018 Operating loss: operating costs were 807% of revenue.
2019 Operating loss: operating costs were 287% of revenue.
2020 Operating loss: operating costs were 209% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	355000	130036000 Derived	-129681000	7800000 Derived	-137481000	-109977000 Derived	Source 2017-01-01 – 2017-12-31: 355000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -129681000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -137481000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -107831000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2146000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	22524000	181726000 Derived	-159202000	10457000 Derived	-169659000	-161271000 Derived	Source 2018-01-01 – 2018-12-31: 22524000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -159202000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -169659000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -160419000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 852000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	72957000	209228000 Derived	-136271000	13502000 Derived	-149773000	-152652000 Derived	Source 2019-01-01 – 2019-12-31: 72957000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -136271000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -149773000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -148758000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3894000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	85552000	178571000 Derived	-93019000	20687000 Derived	-113706000	-80630000 Derived	Source 2020-01-01 – 2020-12-31: 85552000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -93019000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -113706000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -70561000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 10069000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 85.6M 2020

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	355000	Revenue: 355000 Open source
20182018-12-31	Revenue	22524000	Revenue: 22524000 Open source
20192019-12-31	Revenue	72957000	Revenue: 72957000 Open source
20202020-12-31	Revenue	85552000	Revenue: 85552000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.3% 2020

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 355000 Open source
20182018-12-31	Year over year	6,244.8%	Revenue: 22524000 Open source Revenue: 355000 Open source
20192019-12-31	Year over year	223.9%	Revenue: 72957000 Open source Revenue: 22524000 Open source
20202020-12-31	Year over year	17.3%	Revenue: 85552000 Open source Revenue: 72957000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -108.7% 2020

Net margin -132.9% 2020

Free cash flow margin -94.2% 2020

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-36,529.9%	Operating Income: -129681000 Open source Revenue: 355000 Open source
20182018-12-31	Operating margin	-706.8%	Operating Income: -159202000 Open source Revenue: 22524000 Open source
20192019-12-31	Operating margin	-186.8%	Operating Income: -136271000 Open source Revenue: 72957000 Open source
20202020-12-31	Operating margin	-108.7%	Operating Income: -93019000 Open source Revenue: 85552000 Open source
20172017-12-31	Net margin	-38,727%	Net Income: -137481000 Open source Revenue: 355000 Open source
20182018-12-31	Net margin	-753.2%	Net Income: -169659000 Open source Revenue: 22524000 Open source
20192019-12-31	Net margin	-205.3%	Net Income: -149773000 Open source Revenue: 72957000 Open source
20202020-12-31	Net margin	-132.9%	Net Income: -113706000 Open source Revenue: 85552000 Open source
20172017-12-31	Free cash flow margin	-30,979.4%	Revenue: 355000 Open source Operating Cash Flow: -107831000 Open source Capital Expenditure: 2146000 Open source
20182018-12-31	Free cash flow margin	-716%	Revenue: 22524000 Open source Operating Cash Flow: -160419000 Open source Capital Expenditure: 852000 Open source
20192019-12-31	Free cash flow margin	-209.2%	Revenue: 72957000 Open source Operating Cash Flow: -148758000 Open source Capital Expenditure: 3894000 Open source
20202020-12-31	Free cash flow margin	-94.2%	Revenue: 85552000 Open source Operating Cash Flow: -70561000 Open source Capital Expenditure: 10069000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -70.6M 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-107831000	Operating Cash Flow: -107831000 Open source
20182018-12-31	Operating cash flow	-160419000	Operating Cash Flow: -160419000 Open source
20192019-12-31	Operating cash flow	-148758000	Operating Cash Flow: -148758000 Open source
20202020-12-31	Operating cash flow	-70561000	Operating Cash Flow: -70561000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -80.6M 2020

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-109977000	Operating Cash Flow: -107831000 Open source Capital Expenditure: 2146000 Open source
20182018-12-31	Free cash flow	-161271000	Operating Cash Flow: -160419000 Open source Capital Expenditure: 852000 Open source
20192019-12-31	Free cash flow	-152652000	Operating Cash Flow: -148758000 Open source Capital Expenditure: 3894000 Open source
20202020-12-31	Free cash flow	-80630000	Operating Cash Flow: -70561000 Open source Capital Expenditure: 10069000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

106.6% 2020

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	41%	Total Liabilities: 181043000 Open source Total Assets: 441317000 Open source
20182018-12-31	Liabilities / assets	62.8%	Total Liabilities: 185673000 Open source Total Assets: 295752000 Open source
20192019-12-31	Liabilities / assets	109.2%	Total Liabilities: 237668000 Open source Total Assets: 217560000 Open source
20202020-12-31	Liabilities / assets	106.6%	Total Liabilities: 268586000 Open source Total Assets: 251926000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.09× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	13.02×	Current Assets: 397990000 Open source Current Liabilities: 30572000 Open source
20182018-12-31	Current assets / current liabilities	7.78×	Current Assets: 285042000 Open source Current Liabilities: 36617000 Open source
20192019-12-31	Current assets / current liabilities	5.4×	Current Assets: 195675000 Open source Current Liabilities: 36219000 Open source
20202020-12-31	Current assets / current liabilities	4.09×	Current Assets: 225811000 Open source Current Liabilities: 55268000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	−USD 11.45 million Exact value Exact value: -11446909 USD 2011-01-01 – 2011-12-31: -11446909 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2011-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -11446909 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11446909 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312514194852/flxn-20140331.xml#65969 Filing: 000119312514194852 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 14.98 million Exact value Exact value: -14981619 USD 2012-01-01 – 2012-12-31: -14981619 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2012-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -14981619 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14981619 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312515103253/flxn-20141231.xml#640914 Filing: 000119312515103253 The citation records this snapshot. The page link may show a newer release later.	−USD 13.98 million Exact value Exact value: -13979863 USD 2012-01-01 – 2012-12-31: -13979863 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2012-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -13979863 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13979863 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312515103253/flxn-20141231.xml#633893 Filing: 000119312515103253 The citation records this snapshot. The page link may show a newer release later.	USD 34,914 Exact value Exact value: 34914 USD 2012-01-01 – 2012-12-31: 34914 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2012-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 34914 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 34914 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312515103253/flxn-20141231.xml#640006 Filing: 000119312515103253 The citation records this snapshot. The page link may show a newer release later.	−USD 14.01 million Calculation and evidence -13979863 − 34914 USD Exact free cash flow: -14014777 USD 2012-01-01 – 2012-12-31: -13979863 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 34914 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2012-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -14014777 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13979863 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312515103253/flxn-20141231.xml#633893 Filing: 000119312515103253 Input fundies:CapitalExpenditure: 34914 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312515103253/flxn-20141231.xml#640006 Filing: 000119312515103253 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 18.19 million Exact value Exact value: -18186724 USD 2013-01-01 – 2013-12-31: -18186724 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2013-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -18186724 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18186724 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312516501453/flxn-20151231.xml#100133 Filing: 000119312516501453 The citation records this snapshot. The page link may show a newer release later.	−USD 16.19 million Exact value Exact value: -16186944 USD 2013-01-01 – 2013-12-31: -16186944 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2013-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -16186944 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16186944 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312516501453/flxn-20151231.xml#94128 Filing: 000119312516501453 The citation records this snapshot. The page link may show a newer release later.	USD 405,315 Exact value Exact value: 405315 USD 2013-01-01 – 2013-12-31: 405315 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2013-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 405315 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 405315 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312516501453/flxn-20151231.xml#99613 Filing: 000119312516501453 The citation records this snapshot. The page link may show a newer release later.	−USD 16.59 million Calculation and evidence -16186944 − 405315 USD Exact free cash flow: -16592259 USD 2013-01-01 – 2013-12-31: -16186944 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 405315 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2013-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -16592259 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16186944 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312516501453/flxn-20151231.xml#94128 Filing: 000119312516501453 Input fundies:CapitalExpenditure: 405315 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000119312516501453/flxn-20151231.xml#99613 Filing: 000119312516501453 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 27.31 million Exact value Exact value: -27313664 USD 2014-01-01 – 2014-12-31: -27313664 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2014-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -27313664 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27313664 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459017004006/flxn-20161231.xml#113606 Filing: 000156459017004006 The citation records this snapshot. The page link may show a newer release later.	−USD 23.14 million Exact value Exact value: -23144921 USD 2014-01-01 – 2014-12-31: -23144921 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2014-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -23144921 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23144921 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459017004006/flxn-20161231.xml#143091 Filing: 000156459017004006 The citation records this snapshot. The page link may show a newer release later.	USD 802,481 Exact value Exact value: 802481 USD 2014-01-01 – 2014-12-31: 802481 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2014-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 802481 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 802481 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459017004006/flxn-20161231.xml#143760 Filing: 000156459017004006 The citation records this snapshot. The page link may show a newer release later.	−USD 23.95 million Calculation and evidence -23144921 − 802481 USD Exact free cash flow: -23947402 USD 2014-01-01 – 2014-12-31: -23144921 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 802481 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2014-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -23947402 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23144921 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459017004006/flxn-20161231.xml#143091 Filing: 000156459017004006 Input fundies:CapitalExpenditure: 802481 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459017004006/flxn-20161231.xml#143760 Filing: 000156459017004006 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 46.32 million Exact value Exact value: -46315000 USD 2015-01-01 – 2015-12-31: -46315000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2015-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -46315000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46315000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459018004912/flxn-20171231.xml#113380 Filing: 000156459018004912 The citation records this snapshot. The page link may show a newer release later.	−USD 38.95 million Exact value Exact value: -38949000 USD 2015-01-01 – 2015-12-31: -38949000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2015-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -38949000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38949000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459018004912/flxn-20171231.xml#140118 Filing: 000156459018004912 The citation records this snapshot. The page link may show a newer release later.	USD 5.2 million Exact value Exact value: 5197000 USD 2015-01-01 – 2015-12-31: 5197000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2015-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 5197000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5197000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459018004912/flxn-20171231.xml#140790 Filing: 000156459018004912 The citation records this snapshot. The page link may show a newer release later.	−USD 44.15 million Calculation and evidence -38949000 − 5197000 USD Exact free cash flow: -44146000 USD 2015-01-01 – 2015-12-31: -38949000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 5197000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2015-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -44146000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38949000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459018004912/flxn-20171231.xml#140118 Filing: 000156459018004912 Input fundies:CapitalExpenditure: 5197000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459018004912/flxn-20171231.xml#140790 Filing: 000156459018004912 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 71.89 million Exact value Exact value: -71894000 USD 2016-01-01 – 2016-12-31: -71894000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2016-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -71894000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71894000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/flxn-20181231.xml#128767 Filing: 000156459019005465 The citation records this snapshot. The page link may show a newer release later.	−USD 62.47 million Exact value Exact value: -62472000 USD 2016-01-01 – 2016-12-31: -62472000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2016-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -62472000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62472000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/flxn-20181231.xml#156192 Filing: 000156459019005465 The citation records this snapshot. The page link may show a newer release later.	USD 8.44 million Exact value Exact value: 8440000 USD 2016-01-01 – 2016-12-31: 8440000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2016-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 8440000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8440000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/flxn-20181231.xml#156823 Filing: 000156459019005465 The citation records this snapshot. The page link may show a newer release later.	−USD 70.91 million Calculation and evidence -62472000 − 8440000 USD Exact free cash flow: -70912000 USD 2016-01-01 – 2016-12-31: -62472000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 8440000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2016-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -70912000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62472000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/flxn-20181231.xml#156192 Filing: 000156459019005465 Input fundies:CapitalExpenditure: 8440000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/flxn-20181231.xml#156823 Filing: 000156459019005465 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 137.48 million Exact value Exact value: -137481000 USD 2017-01-01 – 2017-12-31: -137481000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2017-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -137481000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -137481000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/flxn-10k_20191231.htm#3452367 Filing: 000156459020010490 The citation records this snapshot. The page link may show a newer release later.	−USD 107.83 million Exact value Exact value: -107831000 USD 2017-01-01 – 2017-12-31: -107831000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2017-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -107831000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -107831000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/flxn-10k_20191231.htm#2417308 Filing: 000156459020010490 The citation records this snapshot. The page link may show a newer release later.	USD 2.15 million Exact value Exact value: 2146000 USD 2017-01-01 – 2017-12-31: 2146000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2017-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 2146000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2146000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/flxn-10k_20191231.htm#2428435 Filing: 000156459020010490 The citation records this snapshot. The page link may show a newer release later.	−USD 109.98 million Calculation and evidence -107831000 − 2146000 USD Exact free cash flow: -109977000 USD 2017-01-01 – 2017-12-31: -107831000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2146000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2017-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -109977000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -107831000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/flxn-10k_20191231.htm#2417308 Filing: 000156459020010490 Input fundies:CapitalExpenditure: 2146000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/flxn-10k_20191231.htm#2428435 Filing: 000156459020010490 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 169.66 million Exact value Exact value: -169659000 USD 2018-01-01 – 2018-12-31: -169659000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2018-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -169659000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -169659000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#3133248 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 160.42 million Exact value Exact value: -160419000 USD 2018-01-01 – 2018-12-31: -160419000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2018-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -160419000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -160419000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2066313 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	USD 852,000 Exact value Exact value: 852000 USD 2018-01-01 – 2018-12-31: 852000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2018-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 852000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 852000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2077470 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 161.27 million Calculation and evidence -160419000 − 852000 USD Exact free cash flow: -161271000 USD 2018-01-01 – 2018-12-31: -160419000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 852000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2018-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -161271000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -160419000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2066313 Filing: 000156459021012050 Input fundies:CapitalExpenditure: 852000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2077470 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 149.77 million Exact value Exact value: -149773000 USD 2019-01-01 – 2019-12-31: -149773000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2019-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -149773000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -149773000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#3131354 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 148.76 million Exact value Exact value: -148758000 USD 2019-01-01 – 2019-12-31: -148758000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2019-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -148758000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -148758000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2064329 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	USD 3.89 million Exact value Exact value: 3894000 USD 2019-01-01 – 2019-12-31: 3894000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2019-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 3894000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3894000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2075677 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 152.65 million Calculation and evidence -148758000 − 3894000 USD Exact free cash flow: -152652000 USD 2019-01-01 – 2019-12-31: -148758000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3894000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2019-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -152652000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -148758000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2064329 Filing: 000156459021012050 Input fundies:CapitalExpenditure: 3894000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2075677 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 113.71 million Exact value Exact value: -113706000 USD 2020-01-01 – 2020-12-31: -113706000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Net Income: -113706000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -113706000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#3129446 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 70.56 million Exact value Exact value: -70561000 USD 2020-01-01 – 2020-12-31: -70561000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Operating Cash Flow: -70561000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70561000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2062346 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	USD 10.07 million Exact value Exact value: 10069000 USD 2020-01-01 – 2020-12-31: 10069000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Capital Expenditure: 10069000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10069000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2073883 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.	−USD 80.63 million Calculation and evidence -70561000 − 10069000 USD Exact free cash flow: -80630000 USD 2020-01-01 – 2020-12-31: -70561000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 10069000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Flexion Therapeutics Inc · 2020-12-31 Flexion Therapeutics Inc (edgar:1419600) Free cash flow: -80630000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 822d2ae12bae1c583789fb8a38a960e750b13d25c03f609527bad0497430fdcb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1419600?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70561000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2062346 Filing: 000156459021012050 Input fundies:CapitalExpenditure: 10069000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1419600/000156459021012050/flxn-10k_20201231.htm#2073883 Filing: 000156459021012050 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

89 filings · 2,142 latest values · 2,142 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001419600, 1419600, FLXN, edgar:1419600

Also known as Flexion Therapeutics Inc, Flexion Therapeutics, Inc.

Flexion Therapeutics Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2020 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation